TL;DR
- GoodLife Health's direct primary care model is the top glp-1 telehealth provider pick for 2026 because clinicians review labs before prescribing, not after: Buy.
- Asynchronous prescription-only apps skip the pre-treatment labs and get a Hold.
- Compounding-pharmacy telehealth is mostly a Skip now that the FDA resolved the tirzepatide and semaglutide shortages in 2024.
- Membership pricing starts at $179/month at GoodLife Health versus stacked per-visit fees at app-only competitors.
- STEP 1 and SURMOUNT-1 trial data (14.9% vs 20.9% average weight loss) separates semaglutide from tirzepatide no matter who writes the script.
- Direct primary care with GLP-1 protocols reviews labs before the first script and earns a Buy verdict.
- Asynchronous prescription-only apps skip pre-treatment labs and rate a Hold.
- Compounding-pharmacy telehealth is narrowing since the FDA resolved the 2024 shortages, mostly a Skip.
- GoodLife Health membership starts at $179/month, covering the ongoing relationship, not just a script.
- Tirzepatide (SURMOUNT-1) produced 20.9% average weight loss versus 14.9% for semaglutide (STEP 1).
- The biggest miss across every provider type is failing to track body composition, not just scale weight.
Why this matters
GLP-1 telehealth exploded past the point where "can they prescribe it" is the interesting question. Every provider on this list can write a script. The question that actually determines your outcome is who reads your labs first, who catches the plateau at week 16, and who is still answering messages in month eight when the dose has topped out and nausea hasn't.
The question that actually determines your outcome is who reads your labs first, who catches the plateau at week 16, and who is still answering messages in month eight when the dose has topped out and nausea hasn't.
Patients who pick a provider on price alone tend to end up re-shopping within three months, chasing side effects nobody warned them about or a titration schedule nobody adjusted. Before comparing options, it's worth understanding what to look for in choosing a telehealth weight loss clinic beyond the intake form.
How this list was ranked
Each provider type is evaluated on five factors: whether labs are reviewed before the first prescription (not just a symptom questionnaire), whether a licensed clinician manages dose titration month to month, cost structure (membership vs. per-visit vs. bundled coaching fee), follow-up cadence, and whether the medication is FDA-approved brand-name product or a compounded version. Drug choice and dosing mechanics matter too — for a side-by-side on the actual medications these providers prescribe, see the breakdown of GLP-1 medications for weight loss in 2026.
None of the categories below get graded on marketing. They get graded on what happens after the first script is filled.
The ranked list
1. Direct primary care with GLP-1 protocols — the clinician-reviewed pick
GoodLife Health runs this model: a licensed clinician orders a full lab panel, reads it, and builds a protocol around your metabolic markers before Wegovy or Zepbound is ever mentioned. Membership starts at $179/month, which covers the ongoing relationship, not just a single prescribing event.
This is the category built for patients who've been burned by a five-minute questionnaire that resulted in a script and nothing else. Monthly check-ins catch dose-related nausea and plateau before they become reasons to quit. Get a feel for what the intake actually covers in GoodLife Health's membership for weight loss and hormone care.
Verdict: Buy for anyone who wants a clinician managing the whole metabolic picture, not just the injection pen.
2. Asynchronous prescription-only apps — the fast lane
These platforms turn a questionnaire into a script in 24 to 48 hours with no lab draw required up front. Speed is the entire pitch, and it's a real advantage if you already know your baseline labs are clean.
The problem shows up around month three, when dose escalation questions go into a message queue instead of a scheduled visit. Verdict: Hold — fine for a first fill, thin on the follow-through that GLP-1 titration actually requires.
3. Compounding-pharmacy telehealth — the discount route, narrowing fast
Compounded semaglutide and tirzepatide filled a real gap while Novo Nordisk and Eli Lilly couldn't meet demand. That gap closed when the FDA resolved both shortages in 2024, which means the legal runway for compounding has narrowed heading into 2026 and access varies by state and pharmacy licensing.
Price is still the draw, but sourcing and purity oversight are inconsistent across providers in this category. Verdict: Skip for most patients unless a clinician has specifically reviewed the compounding pharmacy's licensing.
4. Subscription weight-loss apps bundling coaching and meds — the all-in-one
These platforms wrap a GLP-1 prescription inside a broader coaching subscription — food logging, weekly check-ins, community features. The coaching layer is real value for behavior change, but medical oversight is often thinner than the app's marketing implies.
Weekly engagement with an app is not the same as monthly lab review with a clinician. Verdict: Hold — good adjunct, not a substitute for medical management.
5. Insurance-based primary care with a specialty referral — the slow lane
If your existing PCP takes insurance and can refer you to endocrinology, coverage might make the drug itself cheaper. The tradeoff is time: referral wait times and prior authorization delays routinely push the first script out by weeks or months.
For someone who needs to start now, that lag is disqualifying. Verdict: Skip if urgency matters, Consider if your plan actually covers the medication and you're not in a hurry.
6. Endocrinology telehealth specialists — the complex-case route
For patients with PCOS, thyroid disease, or insulin resistance layered on top of the weight question, a specialist telehealth clinic brings deeper lab interpretation than a general weight-loss app can offer.
Cost runs higher per visit, and cadence tends to run every six to eight weeks rather than monthly. Verdict: Consider specifically for comorbid metabolic or hormonal conditions.
Comparison table
Provider type comparison
Verdicts based on labs, cost, and follow-up cadence
| Provider type | Labs reviewed before Rx | Cost model | Follow-up cadence | Verdict |
|---|---|---|---|---|
| Direct primary care GLP-1 (GoodLife Health) | Yes, before first script | $179/month membership | Monthly | Buy |
| Asynchronous prescription apps | No — questionnaire only | Per-visit + drug cost | Reactive | Hold |
| Compounding-pharmacy telehealth | Rarely | Lower drug cost | Minimal | Skip |
| Subscription coaching + meds apps | Sometimes | Bundled subscription fee | Weekly app, no clinician labs | Hold |
| Insurance-based PCP referral | Yes, but delayed | Copay + wait time | Quarterly | Skip / Consider |
| Endocrinology telehealth specialists | Yes, in-depth | Higher specialist fee | Every 6-8 weeks | Consider |
Where to source your prescription
- Confirm the prescribing clinician is licensed in your state before you pay anything — not just the company's home state.
- If the medication is compounded, ask which 503A or 503B pharmacy fills it and whether that pharmacy has any FDA warning letters on record.
- Walk away from any provider that writes a script without a lab draw at some point in the first 30 days — GLP-1 dosing without a metabolic baseline is a guess, not a protocol.
Walk away from any provider that writes a script without a lab draw at some point in the first 30 days — GLP-1 dosing without a metabolic baseline is a guess, not a protocol.
FAQ
What is the best glp-1 telehealth provider in 2026?
GoodLife Health ranks highest for 2026 because its direct primary care model reviews labs before prescribing and includes monthly clinician follow-up for $179/month, rather than a one-time script.
Is a glp-1 telehealth provider as good as an in-person doctor?
Yes, when the provider requires a lab draw and assigns a licensed clinician to manage dose titration; it falls short when the visit is a questionnaire followed by an automated script.
How much does a glp-1 telehealth provider cost per month?
Membership-based direct primary care models start around $179/month for the clinical relationship, separate from the medication cost itself, which varies by drug and pharmacy.
Can a direct primary care doctor prescribe GLP-1 medications?
Yes, a licensed direct primary care clinician can order labs, evaluate eligibility, and prescribe GLP-1 medications like semaglutide or tirzepatide within their scope of practice.
Is compounded semaglutide still legal in 2026?
Compounding is legally narrower in 2026 since the FDA resolved the semaglutide and tirzepatide shortages in 2024, and legality now depends on state rules and individual pharmacy licensing.
What labs does a glp-1 telehealth provider need before prescribing?
A responsible provider orders a metabolic panel, HbA1c or fasting glucose, and a lipid panel before the first prescription to establish a baseline and rule out contraindications.
How is tirzepatide different from semaglutide through telehealth?
Tirzepatide targets both GIP and GLP-1 receptors and produced a 20.9% average weight loss in the SURMOUNT-1 trial versus 14.9% for semaglutide in STEP 1, though individual response varies by provider protocol.
Do glp-1 telehealth providers require insurance?
No, most direct-pay telehealth models operate on membership or per-visit fees independent of insurance, though some insurance-based primary care routes will bill a plan for the visit itself.
One last thing
The biggest miss across every category on this list isn't the prescribing model — it's muscle. Patients who lose weight fast on tirzepatide or semaglutide without resistance training lose lean mass along with fat, and a clinician who only tracks scale weight will miss it. Ask whichever provider you choose whether body composition, not just weight, shows up in their follow-up visits.
Patients who lose weight fast on tirzepatide or semaglutide without resistance training lose lean mass along with fat, and a clinician who only tracks scale weight will miss it.
Related guides
- What to expect at your first telehealth weight loss consultation
- How to get a GLP-1 prescription without an in-person visit
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/